Escitalopram for Agitation in Alzheimer's Disease

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

April 5, 2024

Study Completion Date

May 31, 2025

Conditions
Dementia
Interventions
DRUG

Escitalopram

5-15 mg/day (target: 15mg/day if tolerated)

DRUG

Placebo

Masked placebo

Trial Locations (29)

10032

Columbia University, New York

14620

University of Rochester Medical Center, Rochester

15213

Alzheimer Disease Research Center; University of Pittsburgh, Pittsburgh

19001

Abington Neurological Associates, Ltd, Abington

21202

Maryland VA Health Care System, Baltimore

21224

Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore

22903

University of Virginia Adult Neurology, Charlottesville

23510

Eastern Virginia Medical School, Norfolk

29401

Roper St. Francis Healthcare, Charleston

33137

Miami Jewish Health Systems, Miami

43221

Ohio State University, Columbus

67214

Kansas School of Medicine-Wichita Center for Clinical Research, Wichita

72205

Biomedical Research Foundation, Little Rock

University of Arkansas for Medical Sciences, Little Rock

75231

Baylor AT&T Memory Center, Dallas

78229

UT Health San Antonio, San Antonio

85351

Banner Sun Health Research Institute, Sun City

90073

University of California Los Angeles/VA Greater Los Angeles Healthcare System, Los Angeles

90089

University of Southern California Keck School of Medicine Memory and Aging Center, Los Angeles

98007

Northwest Clinical Research Center, Bellevue

02169

Alzheimer Disease Center, Quincy

07601

Hackensack Meridian Health, Hackensack

Unknown

University of Calgary and Foothills Medical Centre, Calgary

Centre for Memory and Aging, Toronto

N6C 0A7

Lawson Health Research Institute/Parkwood Institute, London

M4N 3M5

Neuropsychopharmacology Research Group, Sunnybrook, Toronto

M5B 1W8

Unity Health, Toronto

M6J1H4

Centre for Addiction and Mental Health, Toronto

L1N 5S9

Ontario Shores, Whitby

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

JHSPH Center for Clinical Trials

OTHER